Market Analysis

All Reports

Browse our comprehensive collection of market intelligence reports.

Healthcare|March 2020

Fabry’s Disease Pipeline Analysis 2019 (H1)

Fabry’s Disease Pipeline Analysis report covers more than 15S drugs currently in different phases of development. Fabry’s disease is a rare genetic disorder caused mostly in males than females due to the deficiency of the alpha-galactosidase A (a-Gal A) enzyme which causes a build-up of a type of fat, globotriaosylceramide (Gb3, or GL-3) in the bod

Healthcare|March 2020

Progressive Supranuclear Palsy (PSP) Pipeline Analysis 2018 - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Developments.

Progressive Supranuclear Palsy Pipeline Analysis report covers 8 drugs currently in different phases of development. Progressive Supranuclear Palsy or Steele-Richardson-Olszewski syndrome is a rare brain related disorder which affects body movement, eye movement, balance of the body. It is a FTD disorder associated with a decline in motor function and is similar to Parkinson’s disease. Symptoms include loss of balance, slurring of speech, abnormal eye movements and urinary in

Healthcare|March 2020

Plaque Psoriasis Pipeline Analysis 2018 - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Developments

Plaque Psoriasis Pipeline Analysis report covers 41 drugs currently in different phases of development. Plaque Psoriasis is the most type of Psoriasis and is a chronic, relapsing, inflammatory and inherited skin disorder. The disease is not life threatening but often intractable to treatment. Symptoms of the disease include appearance ofthe Plaques of red skin mostly covered with lose silver coloured scales, discoloration or pitting of nails and plaques of scales

Healthcare|March 2020

Neutropenia Pipeline Analysis 2018 (Q1) - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments

Neutropenia Pipeline Analysis report covers 23 drugs currently in different phases of development. Neutropenia means extremely low count of neutrophils in body. Neutrophils are the type of white blood cells and destroy bacteria and other organisms that cause infection. With the lack of neutrophils in the body people with neutropenia are more likely to develop infections. Neutropenia may be congenital or may be acquired as a result of cancer and cancer treatm

Healthcare|March 2020

Friedreich’s Ataxia Pipeline Analysis 2018 - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments

Friedreich’s ataxia Pipeline Analysis report covers 23 drugs currently in different phases of development. Friedreich’s ataxia (FA or FRDA) is a rare genetic disorder which causes degeneration of the nervous system leading to the coordination and movement problems. The disorder worsens with time where the spinal cord and peripheral nerves become thinner resulting into unsteady movements and impaired sensory functions. It is caused by the mutation of FXN gene and c

Healthcare|March 2020

Alcohol Use Disorder Treatment Pipeline Analysis 2019 (H1)

Alcohol use disorder or alcohol dependence treatment pipeline analysis report covers more than 10 drugs currently in different phases of development. Alcohol dependence is a medical and behavioral disease which is characterized by alcohol-induced disturbances in brain structure, neurochemistry, and behavior. The major characteristics of alcohol dep

Healthcare|March 2020

Smoking Cessation Pipeline Analysis 2018 - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments

Smoking Cessation Pipeline Analysis report covers 12 drugs currently in different phases of development. Smoking cessation means discontinuing or quitting smoking which is generally difficult and prolonged due to nicotine addiction. Smoking is the most common preventable cause of death. Quitting requires in general several attempts. People who discontinue often start again because of withdrawal symptoms such as nicotine cravings, weight gain, stress, anxiety etc.

Healthcare|March 2020

Acute Kidney Injury (AKI) Pipeline Analysis 2018 - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments

Acute Kidney Injury (AKI) Pipeline Analysis report covers more than 10 drugs currently in different phases of development. Acute Kidney Injury (AKI) formerly known as Acute Renal Failure (ARF) is caused due to the sudden decrease in the renal or kidney function. This means that the kidney has lost it ability to filter waste and toxins from the body including the dysregulation of extracellular fluid volume. AKI can be classified into intrinsic, pre-renal and post-r

Healthcare|March 2020

Gaucher Disease Pipeline Analysis 2018 (Q1) - Forecasts From 2019 To 2024

Gaucher’s Disease Pipeline Analysis report covers 10 drugs currently in different phases of development. Gaucher’s Disease is a recessive genetic metabolic disorder where there is an inadequate degradation of a specific lipid known as glucocerebroside leading to the build-up of this specific lipid in the liver, spleen, bone marrow and nervous system which interferes with their normal functioning. Major clinical symptoms include, enlargement of spleen and liver als

Healthcare|March 2020

Eosinophilic Esophagitis Pipeline Analysis 2019 (H1)

Eosinophilic Esophagitis Pipeline Analysis 2018 – Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Developments. Eosinophilic Esophagitis Pipeline Analysis report covers more than 10 drugs currently in different phases of development. Eosinophilic esophagitis (EOE) is a chronic allergic or immune conditio

Healthcare|March 2020

Hemochromatosis Pipeline Analysis 2018 (Q1) - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments

Hemochromatosis Pipeline Analysis report covers more than 10 drugs currently in different phases of development. Iron overload means presence of excessive iron in the body. This excessive iron is stored in tissues and organs such as liver, heart etc causing damage to them. Hemochromatosis may be hereditary or acquired due to multiple blood transfusions or intake of excessive iron supplements. The report provides Hemochromatosis treatment drugs

Business Opportunities|March 2020

Denmark Air Freight Logistics Market - Strategic Insights and Forecasts (2022-2027)

<div id="tabs" class="ui-corner-all ui-tabs ui-widget ui-widget-content" style="-webkit-text-stroke-width: 0px; background-attachment: initial !important; background-clip: initial !important; background-color: #fcfcfc; background-image: initial !important; background-origin: initial !important; background-position: initial !important; background-repeat: initial !important; background-size: initial !important; border: none !important; box-sizing: border-box; color: #000000; font-family: Helvetica